| Winlevi (Clascoterone) cream 1% | Sun Pharmaceutical | Approved | Active | |
| Winlevi (clascoterone) 1% & Duac gel | Sun Pharmaceutical | Approved | Completed | |
| Winlevi (clascoterone) 1% cream | Sun Pharmaceutical | Approved | Completed | |
| Winlevi (clascoterone) 1% cream | Sun Pharmaceutical | Approved | Completed | |
| Winlevi (clascoterone) 1% cream | Sun Pharmaceutical | Approved | Completed | |
| Winlevi (clascoterone) 1% & Adapalene 0.3% gel | Sun Pharmaceutical | Approved | Completed | |
| Olumacostat Glasaretil Gel, 5.0% | Eli Lilly | Phase 3 | Completed | |
| Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.) | Torrent Pharmaceuticals | Phase 3 | Completed | |
| Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel + DUAC® Gel + Placebo | Zydus Lifesciences | Phase 3 | Completed | |
| Olumacostat Glasaretil Gel, 5.0% | Eli Lilly | Phase 3 | Completed | |
| DFD-03 | Dr. Reddy's Laboratories | Phase 3 | Completed | |
| DFD-03 (0.1% tazarotene) Lotion + DFD-03 (0% tazarotene) Lotion (Placebo) | Dr. Reddy's Laboratories | Phase 3 | Completed | |
| ADPS topical product + Placebo Control | Sun Pharmaceutical | Phase 2 | Completed | |
| Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% | Dr. Reddy's Laboratories | Phase 2 | Completed | |
| DFD-03 Lotion, 0.1% + Tazorac Cream, 0.1% + DFD-03 Vehicle Lotion 0% + Tazorac Vehicle Cream 0% | Dr. Reddy's Laboratories | Phase 2 | Completed | |
| Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel | Sun Pharmaceutical | Phase 1 | Completed | |
| Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) | Sun Pharmaceutical | Phase 1 | Completed | |
| Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) | Sun Pharmaceutical | Phase 1 | Completed | |
| Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Adapalene Gel 0.3% + Differin® + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| CLPG Topical Gel 1% + Clindamycin + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Test. + Aczone Gel 5% + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin Phosphate + Clindamycin Phosphate RLD + Placebos | Sun Pharmaceutical | Phase 1 | Completed | |
| Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo Control | Sun Pharmaceutical | Phase 1 | Completed | |
| Tretinoin cream, 0.05% + RETIN-A® (tretinoin) cream, 0.05% + Vehicle of the test product | Sun Pharmaceutical | Phase 1 | Completed | |
| DPSG 7.5% + Aczone + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Tretinoin Gel Microsphere, 0.04% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04% + Placebo Control | Sun Pharmaceutical | Phase 1 | Completed | |
| Tretinoin cream 0.1% + RETIN-A® Cream + Vehicle of the test product | Sun Pharmaceutical | Phase 1 | Completed | |
| Tazarotene Cream 0.1% + Tazorac® + Placebo | Sun Pharmaceutical | Phase 1 | Completed | |
| Tretinoin Cream 0.025% | Sun Pharmaceutical | Phase 1 | Completed | |